RxDoctor Payments Data

Ajoy Jana, MD

Orthopaedic Surgery · Elkhorn, NENPI 1851407449

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (32.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medical Device Business Services, Inc. at 58.3% of the total. Reporting peaked in 2019 at $5,097 and has fallen 75.0% since, to $1,276 in 2025.

$7,803in general payments, 2019–2025

Across 40 payments — averaging $195.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$5K
  • Sanara Medtech Inc.$1K
  • Zimmer Biomet$1K
  • Johnson & Johnson$441
  • Medtronic$224
  • Stryker$155
  • plus $228 from 4 others

What the payments were for

  • Consulting fees$1,80023%
  • Speaking & faculty fees$1,00013%
  • Travel & lodging$2,52532%
  • Food & beverage$2,25029%
  • Education$2273%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,803 in reported general payments places this provider in the 70th percentile of 155 orthopaedic surgery providers in Nebraska.

See all orthopaedic surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$309,971
Medicare patients
522
Services billed
6,480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib83$2,827
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen155$2,033
Mupirocin106$651
Omeprazole130$594
Meloxicam188$472
Pantoprazole Sodium44$219
Tramadol Hcl58$202
Oxycodone Hcl19$123
Ondansetron OdtOndansetron13$100
Prednisone22$92

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Elkhorn

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →